Zoledronic acid is not equally potent on osteoclasts generated from different individuals - osteoclasts from smokers are less sensitive
Anais M.J. Møller,
Jean-Marie Delaissé,
Jacob B. Olesen,
Troels Bechmann,
Jonna S. Madsen,
Luisa M. Canto,
Silvia R. Rogatto,
Kent Søe
Affiliations
Anais M.J. Møller
Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; Corresponding author at: Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Jean-Marie Delaissé
Clinical Cell Biology, Dept. of Pathology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Jacob B. Olesen
Clinical Cell Biology, Dept. of Pathology, Odense University Hospital, Odense, Denmark
Troels Bechmann
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; Department of Oncology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark
Jonna S. Madsen
Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Luisa M. Canto
Department of Clinical Genetics, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark
Silvia R. Rogatto
Department of Regional Health Research, University of Southern Denmark, Odense, Denmark; Department of Clinical Genetics, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark
Kent Søe
Clinical Cell Biology, Dept. of Pathology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark; OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark
